Incyte Corp. (INCY): Price and Financial Metrics
INCY Price/Volume Stats
| Current price | $68.81 | 52-week high | $83.95 |
| Prev. close | $71.22 | 52-week low | $53.56 |
| Day low | $68.59 | Volume | 2,018,800 |
| Day high | $70.89 | Avg. volume | 1,917,612 |
| 50-day MA | $62.68 | Dividend yield | N/A |
| 200-day MA | $67.73 | Market Cap | 13.32B |
INCY Stock Price Chart Interactive Chart >
Incyte Corp. (INCY) Company Bio
ncyte is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland. The company was created in 2002 through the merger of Incyte Pharmaceuticals, founded in Palo Alto, California in 1991 and Incyte Genomics, Inc. of Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. (Source:Wikipedia)
INCY Price Returns
| 1-mo | 7.84% |
| 3-mo | 13.59% |
| 6-mo | -0.04% |
| 1-year | 12.00% |
| 3-year | -3.45% |
| 5-year | -34.72% |
| YTD | -0.38% |
| 2024 | 10.00% |
| 2023 | -21.83% |
| 2022 | 9.43% |
| 2021 | -15.61% |
| 2020 | -0.39% |
Continue Researching INCY
Want to do more research on Incyte Corp's stock and its price? Try the links below:Incyte Corp (INCY) Stock Price | Nasdaq
Incyte Corp (INCY) Stock Quote, History and News - Yahoo Finance
Incyte Corp (INCY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...